In a significant step towards enhancing the All-Weather China-Africa Community with a Shared Future, Shanghai Shenlian Biomedical Co., Ltd. (Stock Code: 688098), a leading national high-tech enterprise in veterinary biological products, welcomed Dr. Mohamed Faouzi Kechrid, President of the African Veterinary Association, to its facilities.

This visit underscores Shenlian Biomedical's commitment to fostering a comprehensive partnership that aligns with the principles of the All-Weather China-Africa Community with a Shared Future, aiming to drive high-quality development in the African livestock sector. This strategic dialogue focuses on leveraging collaborative efforts to advance animal health management, disease prevention and control initiatives across Africa.

During the visit, Dr. Kechrid was given a comprehensive tour of Shenlian Biomedical's state-of-the-art R&D center and production facilities, showcasing the company's cutting-edge research in veterinary vaccines, diagnostic reagents, and therapeutic products. His insights and appreciation for Shenlian Biomedical's innovative approach to global animal health solutions were highly valued.

"Shenlian Biomedical is at the forefront of veterinary science and technology, and our collaboration holds immense potential for bolstering Africa's livestock industry," said Dr. Kechrid. "Together, we can achieve sustainable growth and enhance the well-being of animals, which is pivotal for food security and economic prosperity in Africa."

Shenlian Biomedical's management, R&D, and international business teams engaged in profound discussions with Dr. Kechrid, exploring avenues for cooperation in vaccine and diagnostic product exports, technical service overseas, joint R&D projects, and aligning with the future trajectory of the industry. The company's dedication to the African region's animal health management was met with Dr. Kechrid's enthusiastic support, paving the way for a robust and enduring partnership.

"Shenlian Biomedical is deeply committed to our partnership with the African Veterinary Association and other African entities," stated a Shenlian Biomedical representative. "We are eager to contribute to the upliftment of Africa's animal disease prevention and control capabilities through our product, services, technical training, and collaborative R&D efforts."

This visit marks a milestone in the ongoing collaboration between Shenlian Biomedical and the African Veterinary Association, signifying a new era of joint endeavors aimed at the high-quality development of the African livestock industry, in line with the vision of the All-Weather China-Africa Community with a Shared Future.